The weak antitumor efficacy and limited lifespan are the main obstacles that hinder the therapeutic effect of cytokine-induced killer (CIK) cell immunotherapy. In the study, we enhanced the persistence and the antitumor efficacy of CIK cell through PD-1 knockout and hTERT transduction.
Background
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, ranking fifth in prevalence and second in mortality [1] . The 5-year survival rate of HCC patients remains about 10-20% [2] . To improve the survival rate, scientists have developed a variety of novel treatments, of which, adoptive CIK cell therapy is one of the promising [3] . CIK cells as adjuvant therapy for patients with HCC could significantly improve their median survival time and reduce the tumor recurrence rate [4] . However, the killing function of CIK cells is not very powerful, and the CIK cells cannot persist in vivo very long. These are the main obstacles that limit the antitumor efficacy of CIK cells and so their clinical application.
PD-1, a T cell surface inhibitory receptor, is mainly expressed on activated T cells [5] , and it is also one of the molecular markers of T cell exhaustion [6] . PD-1 exerts negative effects on the effector function of CD8 + T cells and blockade of PD-1 with antibodies could improve the function of intratumoral effector T cells [7] . Some researchers have proved that PD-1 knockout using the gene editing technology such as the CRISPR/Cas9 system could enhance antitumor efficacy of primary T cells and Chimeric Antigen Receptor (CAR) T cell [8, 9] . However, the study on the function of PD-1 knockout CIK cells has not been reported. Here we hypothesize that PD-1 knockout can enhance the antitumor efficacy of CIK cells.
Another factor that affects the therapeutic effects of CIK cells is the limited replicative lifespan, which can lead to the replicative senescence in CIK cells. Senescent CIK cells have lost the proliferative capacity and antitumor efficacy. The lifespan of the cells has been found to be related to telomere length, which can be increased by the hTERT gene. Longer telomeres of the infused cells have been found to be associated with objective response of cell transfer therapy in patients with metastatic melanoma [10] .
The aim of our study was to develop an efficient and feasible strategy to knock out the PD-1 gene and transduce the hTERT gene into CIK cells. On this basis, we also investigated whether the Cas9 RNP-mediated PD-1 knockout in CIK cells could enhance their antitumor ability and hTERT transduction could prolong the lifespan of PD-1 KO/CIK cells. Through our study, we hope to develop a new adoptive immunotherapeutic strategy for HCC patients with CIK cells modified by CRISPR technology and hTERT transduction.
Material and Methods

Reagents and cell culture
Human peripheral blood was obtained from HCC patients of Beijing Shijitan Hospital, Capital Medical University. Written informed consent was obtained from these patients, and the study was approved by the hospital ethics committee. The human hepatocellular carcinoma cell line SMMC-7721 was purchased from American Type Culture Collection (ATCC) and cultured in DMEM high-glucose medium (GIBCO, US) supplemented with 10% FBS (GIBCO, US), 100 U/ml penicillin, and 100 μg/ml streptomycin; all cells were cultured in a humidified cell incubator at 37°C and 5% CO 2 .
Expansion of CIK cells
CIK cells were prepared as previously described [11] . In short, PBMCs separated from peripheral blood by Ficoll-Hypaque gradient centrifugation were suspended in GT-T551 serumfree medium supplemented with 10% FBS and 1000 U/mL IFN-g (PeproTech, US). The next day, 50 ng/mL anti-CD3 antibody (eBioscience, US) and 100 U/mL recombinant human IL-2 (eBioscience, US) were added to the cell culture medium. Half of the volume of the cell culture medium was exchanged with the fresh GT-T551 serum-free medium (Takara, Japan) containing 100 U/mL recombinant human IL-2 every 2 days to maintain the cell concentration at 2×10 6 cells/ml. CIK cells were collected on the 14 th day to analyze the phenotype and cytotoxicity of CIK cells.
In vitro transcription of sgRNAs
Three gRNAs (Supplementary Table 1) were designed with 2 CRISPR design tools (http://crispr.mit.edu and https://portals. broadinstitute.org/gpp/public/). PX330 plasmid (Addgene plasmid #4223) was used as a template and the T7 promoter+20-bp target sequence oligonucleotide +20-bp sgRNA scaffold was used as forward primer (Supplementary Table 1 ). After the in vitro transcription template of T7-sgRNAs was amplified by PCR, the sgRNAs were transcribed in vitro using a HiScribe T7 Quick High Yield RNA Synthesis Kit (NEB, US). The in vitro transcription single-guide RNAs (IVT sgRNAs) were purified by using RNA clean & concentratorTM-25 (Zymo Research, US), eluted in RNase-free water, and used immediately after elution or stored at -80°C.
Preparation of PD-1 knockout CIK cells
PD-1 knockout CIK cells were obtained by the electroporation of Cas9 RNPs as described in a previous report [12] . 5×10 Germany). After electroporation, the cells were resuspended in 2.5 ml pre-warmed cell culture medium in 6-well cell plates. 48 h later, the cells were harvested for the next experiments.
TIDE analysis, T7E1 mismatch cleavage assay, and Sanger sequencing The mutations were checked by TIDE analysis, T7E1 mismatch cleavage assay, and clone sequence analysis. Cells were harvested 48 h after electroporation and genomic DNA was extracted. The genome region, including the PD-1 knockout site, was amplified and Sanger sequencing was performed on the purified PCR products. The sequencing results were used to perform TIDE analysis with online TIDE software (http://tide.nki.nl) to assess the knockout efficiency. A T7E1 assay of the purified PCR product was also performed using an EnGen Mutation Detection Kit (NEB, US) to validate the knockout efficiency. To analyze the indels of the PD-1 target site, the purified PCR fragment was cloned into the pGEM-T EASY vector (Promega, US) to assess the mutant alleles. Using blue-white screen experiments, a total of 40 positive colonies were obtained and sequenced by using universal primer M13F. The primer sequences used in these assays were listed in Supplementary Table 1 .
Flow cytometry
The immunophenotype of wild-type CIK cells and PD-1 knockout CIK cells were analyzed using flow cytometry. Briefly, 5×10 6 wild-type CIK cells and PD-1 KO/CIK cells were resuspended in 100 μL PBS buffer. The monoclonal antibodies CD3-PerCP-Cy5.5, CD4-FITC, CD8-APC, CD56-PE, CD45RO-PE, CD45RA-FITC, CD27-Brilliant Violet 421, and CD279(PD-1)-PE were added. All antibodies were purchased from BD Bioscience (San Diego, CA, US). Samples were incubated for 30 min at 4°C in the dark and then tested with a FACSAriar flow cytometer. Flow cytometry data were analyzed with FlowJo v.10.2 (TreeStar, USA).
Lentiviral transduction of hTERT gene into the PD-1 KO/ CIK cells
To transduce hTERT gene into PD-1 KO/CIK cells, the lentiviral transduction was used as described in a previous study [13] . The hTERT lentiviral particles were produced by a lipofectamine transfection system with hTERT lentiviral vector (Hanbio Biotechnology, China). Lentiviral particles were concentrated and virus titration was examined with HIV-1 p24 core profile ELISA (PerkinElmer, Waltham, MA, US). After electroporation of Cas9 RNPs, PD-1 KO/CIK cells were transduced with hTERT lentiviral particles at multiplicity of infection of 50. The cells are harvested for the next step in our experiments 96 h later.
Western blot analysis
The hTERT expressions were detected by Western blotting and compared to b-actin, as previously described [14] . The proteins were obtained from the cell and quantified. After separation using SDS-PAGE, the proteins were transferred to a nitrocellulose membrane. The membrane was blocked using 5% non-fat milk for 1 h at room temperature and then incubated with rabbit anti-hTERT antibody (Abgent, US) overnight at 4°C followed by incubation with an infrared secondary antibody (LI-COR, US) for 1 h at room temperature prior to detection with the Odyssey imager (LI-COR, US). ImageJ software was used to assay the intensity of each band.
Cell proliferation assay
Based on the cell number count, the proliferation curves were obtained by the population doubling (PD) level. The PD levels were determined using the formula: PD(n)=log2(Nn/N 0 ) (n, passage; Nn and N 0 are the number of cells at the passage n and passage 0) [15] .
ELISPOT assay
We performed an ELISPOT assay to assess IFN-g production of CIK cells after activation with SMMC-7721 cells. A total of 5×10 3 
SMMC-7721 cells (target cells) and 1×10
5 effector cells (wild-type CIK cells, PD-1 KO/CIK cells or hTERT/PD-1 KO/CIK cells) were added to precoated wells at a ratio of E: T=20: 1. After incubation for 16-18 h, the frequency of CIK cells stimulated was measured using an IFN-g ELISPOT Kit (Dakewei, China). Plates were analyzed using an ELISPOT analyzer (Cellular Technology Ltd., US).
Luciferase-mediated cytotoxicity assay
The cytotoxicity of CIK cells was examined using luciferasemediated cytotoxicity assay as previously described [23] . In short, the hepatocellular carcinoma cell line SMMC-7721 with luciferase and GFP proteins were established by lentivirus infection. Based on different effect target ratios, SMMC-7721 cells and effector cells (wild-type CIK cells, PD-1 KO/CIK cells or hTERT/PD-1 KO/CIK cells) were mixed and cultured in white 96-well fluorescence-detected plates at 37°C for 16-18 h. After the 100 μL substrate mixture was added, fluorescence values were tested immediately. The killing rate was calculated using the following formula: {%special lysis= [1-(fluorescence value of target cell co-culture well)/(fluorescence value of target cell well)] ×100}.
Measurement of telomere length
Telomere lengths were quantified using Quantitative Fluorescent in situ Hybridization (Q-FISH) as previously described. In brief,
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hTERT/PD-1/CIK cells were harvested at 7 days after hTERT transfection and treated with colcemid for 3 h before added into hypotonic KCl solution and fixed in methanol-acetic acid. Cy-3 labeled (CCCTAA)3 PNA probe (Panagene, Korea) was used to bind the telomere in the end of the chromosome. The fluorescence images of telomeres and chromosomes were obtained using a laser confocal microscope using a 100×oil objective. The relative telomere length was determined by fluorescence intensity using TFL-Telo software. Absolute telomere length was measured using the qPCR method described previously [16] . Two oligomer standards were introduced to generate the standard curve of telomere and single copy gene. Based on both standard curves, the absolute telomere length was measured using the PCR data.
Karyotype analysis
Karyotype analysis of hTERT/PD-1 KO/CIK cells was performed using Giemsa staining at 60 days after hTERT transfection. Briefly, preparation of metaphase spreads was performed as the Q-FISH procedure above. After digestion with 0.25% trypsin, G-banding of metaphase slides was obtained by Giemsa staining and analyzed by a karyotyping system from Applied Imaging Corporation.
Statistical analysis
All experiments were performed independently 3 times. The results are presented as mean ± standard error. Two-tailed Student's t-test was applied for analyzing the data, which was performed using GraphPad Prism6 software. P values of 0.05 or less were defined as statistically significant.
Results
Screen for the most effective sgRNA and generation of PD-1 knockout CIK cells To achieve effective gene knockout, 3 sgRNAs targeting the first exon of PD-1 ( Figure 1A) were designed. Both T7E1 mismatch cleavage assay and TIDE analysis showed that knockout efficiency of sgRNA1 to be highest, reaching 41.23±0.52% (TIDE method) ( Figure 1B, 1C) . The sgRNA1 target region was amplified and sub-cloned to identify mutant alleles. Of the 40 sequenced alleles, 16 were mutants, confirming the mutation of the PD-1 knockout site. As shown in Figure 1D , all the mutations occurred precisely in the sgRNA1 targeting region.
Phenotype of CIK cells after PD-1 knockout
As shown in Figure 2A Figure 2B , 2C, the immunophenotype of PD-1 KO/CIK cells was approximately similar to that of wildtype CIK cells, which was roughly similar to that the CIK cell immunophenotype reported in previous literature [17] .
Delivery of hTERT increased hTERT protein expression and enhanced proliferation of PD-1 KO/CIK cells
To verify the feasibility of the lentiviral transduction of hTERT gene to PD-1 KO/CIK cells, we performed Western blotting to assess the expression of hTERT protein. As shown in Figure 3B, 3C , a higher level of hTERT protein can be confirmed significantly in hTERT/PD-1 KO/CIK cells. To assay cell proliferation, PDs were calculated by cell count. As shown in Figure 3A , the CIK cells and PD-1 KO/CIK cells could expand 19-25 population doublings (PDs), whereas hTERT/PD-1 KO/CIK cells continue expand 30-40 PDs, which was a significant difference.
PD-1 knockout enhanced antitumor function of CIK cells whereas hTERT transduction did not affect antitumor function of PD-1 KO/CIK cells.
To assess the functional characteristics of CIK cells, we performed IFN-g ELISPOT and cytotoxic assays. In the IFN-g ELISPOT assay, IFN-g secreting capacity of cells was detected by counting the number of spots. As shown in Figure 3D , there were significantly more spots in PD-1 KO/CIK cells than wild-type CIK cells (90.00±1.52 vs. 24.00±2.52), which indicated that knockout of PD-1 enhanced the cellular immune response of CIK cells to HCC cell line. However, the number of spots in hTERT/PD-1 KO/CIK cells was similar to that of PD-1 KO/CIK cells, which showed that hTERT transduction did not alter the IFN-g secreting capacity of PD-1/CIK cells. Figure 3E showed luciferase-based cytotoxicity assay against the hepatocellular carcinoma SMMC-7721 cell line. As shown in Figure 3E , the killing efficacy of PD-1 KO/CIK cells derived from patients with HCC were significantly stronger than wildtype CIK cells (P<0.05), whereas among PD-1 KO/CIK cells and hTERT/PD-1 KO/CIK cells, there was no difference in killing efficacy, which indicated that hTERT transduction did not alter the cytotoxicity of PD-1/CIK cells.
hTERT transduction could prolong the telomere of PD-1 KO/CIK cells KO/CIK cells. According to the histogram of the telomere fluorescence, the relative telomere length of hTERT/PD-1 KO/CIK cells was significantly longer than that of wild-type CIK cells and PD-1 KO/CIK cells, whereas the relative telomere length of wild-type CIK cells and PD-1KO/CIK cells showed no difference. The result was validated by the findings obtained using the qPCR method ( Figure 4B ).
hTERT transduction did not affect the karyotype of PD-1 KO/CIK cells
To determine whether hTERT transduction could lead to the malignancy of PD-1 KO/CIK cells, the integrity of the chromosome structure was assessed using a karyotype assay. As shown in Figure 4C , the karyotype assay of hTERT/PD-1 KO/CIK cells demonstrated a normal karyotype without structural chromosome changes. 
Discussion
In our study, we explore a promising strategy to enhance the antitumor efficacy and the lifespan of CIK cells through CRISPR/Cas9 system and hTERT transduction. First, we screened the optimal sgRNA to knock out PD-1 effectively. Using the sgRNA, we knocked out the PD-1 gene of CIK cells was knocked out at an acceptable rate of efficacy. PD-1 knockout was found to significantly enhance the antitumor efficacy of CIK cells and to have no effect on the phenotype. After PD-1 knockout, PD-1 KO/CIK cells with hTERT overexpression were obtained by lentiviral transduction of hTERT. hTERT/PD-1 KO/CIK cells had a longer lifespan and more pronounced antitumor ability against hepatocellular carcinoma cell line than CIK cells.
The expression of PD-1 is low in CIK cells (Figure 2 ), but it can be upregulated when CIK cells are activated by antigen or stimulant. PD-1 knockout can inhibit the redistribution of PD-1, which can mitigate the negative effect of PD-1 and enhance the function of CIK cells. In our study, the PD-1 expression of CIK cells was very low (4.54±0.28%), but after PD-1 knockout, the antitumor capacity was improved significantly. Furthermore, PD-1 is not involved in the process of T cell differentiation, so PD-1 knockout had no effect on the phenotype of CIK cells (Figure 2) . These results were consistent with those of previous studies [8, 9] .
There are many factors that affect the in vivo efficiency of adoptive cell therapy, and the persistence in the body is one of the most significant [18] . Long-term persistence of immune cells in vivo has been found to be related to a durable response effect to tumor [19] . However, when immune cells of in vitro culture reach 19-25 PDs, the immune cells began to enter the senescent state and both the proliferative capacity and antitumor efficacy are decreased [20] . In the present study, after transfection of hTERT gene, the telomere length of PD-1 KO/CIK cells was 
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doubled. When PD-1 KO/CIK cells reached 40-50 PDs, the cells remained in the cell proliferation phase, which showed that the lifespan of PD-1 KO/CIK cells had been prolonged. These were consistent with the results of previous studies [14] . More importantly, hTERT transduction does not alter the chromosomal structure. However, this was a mid-term (60-day) observation of the chromosomal structure. Long-term chromosome observations need to be further developed. + T cells of CIK cells are the main cell component that plays an important role in antitumor effects [21, 22] . However, for a variety of cellular components, it was still unclear which component of CIK cells plays the most significant role after PD-1 knockout and hTERT transduction. This should be established in further studies performed in vitro and in vivo.
Conclusions
Our study showed that PD-1 knockout combined with hTERT transduction could prolong the lifespan and enhance antitumor efficacy of CIK cells against hepatocellular carcinoma cell line, which is an efficient and safe method to prepare robust engineered immune cells for adoptive cell immunotherapy against hepatocellular carcinoma.
